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nave abundance and the protein levels for MMPs, respectively. 
Results: One micro mollL BNP significantly (pcO.01) enhanced zymographic gelatinase- 
A (MMP-2) abundance. In addition, protein expressions of MMP-1. -2, -3 and membra- 
nous type-l MMP were significantly increased by BNP, while MMP-9 and MMP-13 were 
unchanged. The cGMP analogue &bromo-cGMP (lo4 moliL) mimicked the BNP effect, 
whereas inhibition of protein kinase G (PKG) by KT5823 (lo* moUL) significantly 
(p-zO.05) attenuated BNP-induced zymographic MMP-2 abundance. ET-l (lo” mti) 
down-regulated the zymographic MMP-2 abundance and BNP reversed the action of ET- 
1, while TNF-alpha (lO-7 mol/L) increased BNP-induced zymographic MMP-2 abundance 
in a synergistic manner. 
Conclusions: This study reports that BNP increases MMPs via cGMP-PKG signaling. In 
addition, cross-talk between BNP and ET-l, TNF-alpha results in different biological 
effects. These findings suggest that BNP participates in the remodeling of myocardial 
structure in the progression of heart failure via the control of cardiac fibroblast function. 
2:30 pm. 
409-3 Identification of Differential Gene Expression Patterns 
in Patients With End-Stage lschemic and Noniachemic 
Cardiomyopathies 
Xinaiana Han, David Fermin. Jennifer Hall, Soon Park, Richard A. King, Leslie W. Miller, 
University of Minnesota Medical School, Minneapolis, MN 
Background: End-stage cardiomyopathy (ESCM) is associated with altered expressions 
of muitiple genes. Unloading by the left ventricular assist device (LVAD) which results in 
recovery of hemodynamic and cellular abnormalities may lead to further dynamic gene 
expression changes. 
Methods: A microarray technique representlng approximately 2l3 of known human 
genome (22283 genes, Affymetrix) was used to probe paired left ventricular samples 
from 15 patients (7 ischemic, 8 non-ischemic, on LVAD for 1 to 22 months) obtained at 
LVAD implant and transplantation; real-time polymerase chain reaction (RT-PCR) was 
used to further confirm selected gene transcript changes. 
Results: At a p value of ~0.01, at least 196 genes encompassing both cell structure pro- 
tein/matrix and subcellular signaling proteins regulating inotropy, metabolism, myocardial 
hypertrophy and apoptosis were differentially expressed between ischemlc and non- 
ischemic ESCM. In ischemlc ESCM, LVAD support resulted in increase of 68 genes and 
decrease of 81 genes. In non-lschemic ESCM, LVAD support resulted I” increase of 50 
genes and decrease of 3 genes. Five genes (Ribosomal protein L4, Heterogeneous 
nuclear ribonucleoproteln, Glycine amidinotransferase, Aquaporin 7, and KIAA0713 pro- 
tein) were found concordantly altered in both ischemic and non-ischemic ESCM. How- 
ever, these five genes responded very differently to unloading by LVAD. When patients 
were grouped by the duration of LVAD support (Month: < 2,2-10, >lO), a greater number 
of genes were found altered with longer LVAD support and the majority of genes in each 
of the three duration groups were distinct. RT-PCR experiments using specific primers 
designed for natriuretic peptide precursor B, collagen type la, four and a half LIM 
domains I, and myosin light chain 2a confirmed the microarray finding that the first two 
genes were down-regulated and the last two genes were up-regulated following LVAD. 
Conclusion: lschemic and non-ischemic ESCM are associated with dynamic and differ- 
ential expressions of different genes. Remodeling following LVAD is likely en active pro- 
cess involving activation and inactivation of different functioning groups of genes in the 
two disease entities. 
2:45 p.m. 
from spleen (DSL), 2) surveillance right ventricular endomyocardial biopsies (EMB) 
obtained at l-week and l-year after transplantation in 28-patients (age: recipient 55 f 
11.8; donor 32 *7 years) who had a paired IVUS within 4-weeks and at one year after 
transplantation for the volumetric assessment of CAV. Results: AT, mRNA expression 
in DSL (median and 25th -75th percentile: 9.9, 3.1 - 23.8 folds relative to calibrator) cor- 
related with that of EMB at l-week (1.04, 0.6 - 2.0 folds; r = 0.60, P = 0.001) and at 1-yr 
(1.5, 0.6 - 3.8 folds; r = 0.66, P = 0.0003) after transplantation. mRNA expression of AT, 
in DSL (CMIT: r=0.73. PC 0.0001; CPV: r = 0.69, P < 0.0001) and EMB at 1 -week (CMIT: 
r=O.52, F10.005;CPV: r=0.56. EO.002) and at 1-yr (CMIT: rc0.63, P < 0.0001; CPV: 
r=0.43, F10.004) aHer transplantation were univariate predictors of CAV. Multivariate 
analysis showed that mRNA expression of AT, in DLS (P= 0.01) and in l-year EMB (P= 
0.03) as significant predictors of CAV with a combined r of 0.87 and I+ of 0.75. AT, 
expression in DLS (7.4t9.8 vs 22.1+16.0 folds;F=0.004) and in EMBs at l-year (1.3 +1.6 
vs 3.le2.5 folds; P=O.Ol) were higher in recipients (n=l3) demonstrating CAV es a more 
than 0.3mm CMIT from baseline to one year. Conclusions: mRNA expression of AT, in 
DSL correlate with that of early and one-year post transplant cardiac expression. Both 
DSL and cardiac AT, expression predict accelerated progression of CAV supporting a 
potentially important role of Ang II receptor blocker in retarding its progression after 
transplantation. 
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409-l Local Delivery of Culture-Modified Mononuclear Cells 
Improves Endothelial Function and Attenuates 
Neointimal Formation in a Rabbit Balloon Injury Model 
Raiiv Gulatl, Dragan Jevremovic. Timothy E. Peterson, Tyra A. Win, Laurel S. Kleppe. 
Cheryl S. Mueske, Amir Lerman, Richard G. Vile, Robert D. Simari, Mayo Clinic, 
Rochester, MN 
Background: Bone marrow derived progenitor cells have been shown to contribute to 
endothelial replacement following vascular injury. In vitro culture of peripheral blood pro- 
duces cells with phenotypic characteristics of endothelium. We hypothesized that autolo- 
gous delivery of such culture-modified mononuclear cells (CMMC) to balloon injured 
arteries could beneficially modify the vascular response to injury. 
Methods and Results: Rabbit peripheral blood mononuclear cells were cultured on 
fibronectin in endothelial growth media for 7 days yielding cells of endothelial lineage 
(CMMC). Continued culture resulted in highly proliferative outgrowth of cells with distinct 
endothelial phenotype (CD31, eNOS, acetylated LDL uptake). A rabbit model of balloon 
carotid injury was used to evaluate the effect of CMMC delivery on functional and struc- 
tural vascular responses. Animals underwent balloon injury and immediate treatment 
with autologous CMMCs or saline control by 20 minutes of local dwelling or by systemic 
ear vein injection. Fluorescent labeled CMMCs were seen to incorporate into the vessel 
wall following both routes of delivery. Local CMMC administration at the time of balloon 
inlury dramatically improved endothelial dependent vasoreactivity to acetylcholine (Ach) 
at 4 weeks compared with salme treatment (% max relaxation 77.6 +I- 6.4 vs 28.8 +I- 7 6. 
p&lt;0.005; concentration Ach [-log M] to achieve 25% mex relaxation 7.19 +/- 0.04 vs 
5.38 +/- 0.06, p&lt;O.O05). CMMC treatment also significantly reduced neointimal forma- 
tion at 4 weeks (intJmed 0.39 +I- 0.08 vs 0.86 +/- 0.17, p&lt;O.O5). 
Conclusions: These data demonstrate that delivery of CMMCs to balloon injured arteries 
is associated with markedly enhanced endothelial dependent vasoreactivity. Further- 
more, CMMCs delivered at the time of injury significantly reduce subsequent neointimal 
formation. 
2:15 pm. 
409-2 Antifibrotic Property of Brain Natriuretic Peptide in 
Cardiac Fibroblasts: Cross-Talk Action With 
Endothelin-1 and Tumor Necrosis Factor on the 
Induction of Matrix Metalloproteinases 
Toshihiro Tsuruda. Guido Boerngter, Brenda K. Huntley, Josh A. Noser, Alessendro 
Ceteliotti, John C. Burnett, Jr., Mayo Clinic. Rochester, MN 
Background: Cardiac fibroblasts (CFs) produce extracellular matrix (ECM) proteins and 
participate in the remodeling of the heart. Brain natriuretic peptide (BNP) is known to be 
activated in heart failure, and inhibit cellular proliferation; however, it is unknown if BNP 
participates in the degradation of ECM turnover. To understand the role of BNP es an 
anti-fibrotic factor in the progression of heart failure, we examined the effect of BNP and 
its signaling system on the activation of matrix metalloproteinases (MMPs), a key 
enzyme for the degradation of ECM proteins. In addition, we looked at the interactions 
between BNP and a fibrotic factor, endothekn-1 (ET-l), and a pro-inflammatory cytokine, 
TNF-alpha. 
Methods: CFs isolated from normal adult canine ventricle were used. Techniques for 
zymographic gelatlnase assay and Western bloning were employed to detect the gelati- 
409-4 Combinatorial Cytokine Gene Therapy Induces 
Synergistic lmmunosuppression and Tolerance in 
Cardiac Allograft 
Hiroshi Furukawa Kiyohiro Oshima. Hyde Russell, Thomas Tung, Jun Xu, Guanggen 
Cui, Hillel Laks, Luyi Sen, UCLA, Los Angeles, CA 
Background: Previous studies have shown that ex viva interleukrn-10 (IL-lo) gene ther- 
apy suppressed alloimmune responses and prolonged allograft surwval, but true toler- 
ance was not achieved. We assessed the hypothesis that liposome-mediated ex viva 
intracoronary Interleukin-4 (IL-4) and IL-10 comblned gene therapy may generate syner- 
gistic immunosuppression and induce allograft tolerance. 
Methods: A functional cervical heterotopic heart transplant model of rabbits was used to 
evaluate the efficiency and efficacy of the gene therapy. 
Results: The mean survival of cardiac allografl was significantly (pqO.05) prolonged from 
7*1 days in Control Group (CG) to 28a7 days in IL-IO gene therapy Group (IL-1OG) and 
135+20 days in IL-4 and IL-10 combined acne theraov Grow (IL-4&lOGI. The transaene 
and protein expression in IL-4&lOG reached the p&k in pbsioperetive’day (POD)5-8, 
and slowlv reduced thereafter. The reiection score in IL-4&lOG was sionificantlv lower 
(2.2*0.2, bc0.05) than that of CG (3.6iO.2) and IL-1OG (2.7*0.3) in POD<-6, and;.&O.O 
in POD>31. In IL-4&lOG, total graft infiltrating cells was reduced 31% in POD7-10 and 
72% in POD>31, and the percentage of CD3+ T cells was significantly decreased 
(42.7+3.4% in CG, 28.9*5.8% in IL-1OG and 20.9-tO.5% in IL-4&lOG. pcO.01) in POD7- 
10. The percentage of CD4+ T cells was significantly (pqO.01) reduced from 28.9*3.3% 
in CG to 20.9*7.2% in IL-1OG and 13.8+0.3% in IL-4BlOG in POD7-10. The reduction of 
CD&I+ T cells was even more remarkable (19.6+3.4% in CG, 14.1*3.0% in IL-IOG, 
7&0.3% in IL-4&lOG in POD7-10, pcO.01). IL-4 and IL-IO expression was correlated 
with the reduction of the graft infiltrating CD3+ T cells and CD4+/CDB+ ratio (p<O.O5), 
and inversely correlated with the rejection score (p<O.Ol). In IL-4&lOG and IL-lOG, the 
cytotoxic activity of infiltrating T cells III the allografl was greatly reduced (78+8%, and 
69+7%, respectively). 
Conclusion: The liposome-medrated ex viva intracoronary IL-4 and IL-10 combined gene 
